利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

35 条记录 (耗时 0.03 秒)

    Visible light optical polarizer made from stretched H2-treated glass and method of making same
    1.
    发明申请
    Visible light optical polarizer made from stretched H2-treated glass and method of making same 有权
    由拉伸H2处理的玻璃制成的可见光光学偏振片及其制造方法

    公开(公告)号：US20070141350A1

    公开(公告)日：2007-06-21

    申请号：US11314874

    申请日：2005-12-20

    申请人： Nicholas Borrelli ,  David McEnroe ,  David McEnroe ,  Joseph Schroeder

    发明人： Nicholas Borrelli ,  David McEnroe ,  David McEnroe ,  Joseph Schroeder

    IPC分类号： B32B17/00 ,  C03C10/00 ,  C03B23/00

    CPC分类号： C03B32/00 ,  C03C3/064 ,  C03C3/091 ,  C03C14/006 ,  C03C21/007 ,  C03C23/007 ,  C03C2214/08 ,  C03C2214/16 ,  Y10T428/315

    摘要： The invention is directed to a method for preparing visible light optical polarizers using a non-halide silver salt and any glass composition that the non-halide silver salts is soluble, provided that the glass composition, including the silver salt, was a halide content that is, on a molar basis, 10% or less than the silver content, on a molar basis, of the glass composition. The silver containing glass is hydrogen reduced prior to stretching to form an optical polarizer. The invention enables one to form a visible light polarizer having a polarizing layer thickness in the range 10-40 μm in which the silver particles have a surround index sufficiently removed from the blue polarizer region to allow good contrast.

    摘要翻译： 本发明涉及一种使用非卤化物银盐制备可见光光学偏振器的方法和任何非卤化物银盐可溶的玻璃组合物，只要包括银盐的玻璃组合物为卤化物含量， 以摩尔计，为玻璃组合物的基于摩尔的银含量的10％或更少。 含银玻璃在拉伸之前是氢还原以形成光学偏振片。 本发明使得能够形成具有10-40μm范围内的偏振层厚度的可见光偏振器，其中银颗粒具有从蓝色偏振片区域充分去除的环绕指数以允许良好的对比度。

    Visible polarizing glass and process
    2.
    发明申请
    Visible polarizing glass and process 有权
    可见偏光玻璃及工艺

    公开(公告)号：US20070093373A1

    公开(公告)日：2007-04-26

    申请号：US11257968

    申请日：2005-10-24

    申请人： Nicholas Borrelli ,  George Hares ,  David McEnroe ,  Joseph Schroeder

    发明人： Nicholas Borrelli ,  George Hares ,  David McEnroe ,  Joseph Schroeder

    IPC分类号： C03C10/00 ,  C03C1/00

    CPC分类号： G02B5/3025 ,  C03B23/047 ,  C03C3/064 ,  C03C4/08 ,  C03C14/006 ,  C03C2214/08

    摘要： The invention is directed to a silver-containing polarizing boroaluminosilicate glass composition that has been doped with a noble metal selected from the group consisting of Pt, Pd, Os, Ir, Rh and Ru, including mixtures thereof,to nucleate and precipitate silver ions to silver metal without the need for a reducing atmosphere step. The invention is further directed to a method for making the glass composition of the invention. Using the composition and method of the invention, one can prepare a glass having a selected null transmission range.

    摘要翻译： 本发明涉及掺杂有选自Pt，Pd，Os，Ir，Rh和Ru（包括它们的混合物）的贵金属的含银极化硼铝硅酸盐玻璃组合物，以使银离子成核并沉淀 银金属不需要还原气氛的步骤。 本发明还涉及制备本发明的玻璃组合物的方法。 使用本发明的组合物和方法，可以制备具有选定的无效透射范围的玻璃。

    ELECTRODE SURFACE MODIFICATION FOR IMPARTING CURRENT DENSITY DIRECTIONALITY IN LEAD ELECTRODES
    6.
    发明申请
    ELECTRODE SURFACE MODIFICATION FOR IMPARTING CURRENT DENSITY DIRECTIONALITY IN LEAD ELECTRODES 有权
    电极表面修正电极密度电流密度限制

    公开(公告)号：US20110160821A1

    公开(公告)日：2011-06-30

    申请号：US12946214

    申请日：2010-11-15

    申请人： Timothy R. Jackson ,  Joseph Schroeder

    发明人： Timothy R. Jackson ,  Joseph Schroeder

    IPC分类号： A61N1/05 ,  H01R43/20

    CPC分类号： A61N1/056 ,  A61N2001/0585 ,  Y10T29/49208

    摘要： An implantable medical lead having a modified electrode surface for imparting current density directionality within an electrode is disclosed. An implantable medical lead includes a lead body having a proximal section and a distal section having a pre-biased shape configured to secure the lead to an inner wall of a blood vessel. An electrode coupled to the distal section of the lead body includes a number of surface features on an inactive portion of the electrode that impart a current density directionality towards an active portion of the electrode that contacts the inner wall of the vessel. Methods for imparting current density directionality within an implantable lead electrode are also disclosed.

    摘要翻译： 公开了一种植入式医用引线，其具有用于在电极内施加电流密度方向性的改性电极表面。 可植入医疗引线包括具有近端部分的引线主体和具有被配置为将引线固定到血管内壁的预偏置形状的远端部分。 耦合到引线主体的远端部分的电极包括在电极的非活性部分上的许多表面特征，其向接触容器的内壁的电极的有源部分赋予电流密度方向性。 还公开了在可植入引线电极内赋予电流密度方向性的方法。

    Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
    8.
    发明申请
    Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use 失效
    亚硝基化和亚硝基化环加氧酶-2抑制剂，组合物和使用方法

    公开(公告)号：US20070060571A1

    公开(公告)日：2007-03-15

    申请号：US11599519

    申请日：2006-11-15

    申请人： Ramani Bandarage ,  Upul Bandarage ,  Xinqin Fang ,  David Garvey ,  L. Letts ,  Joseph Schroeder ,  Sang Tam

    发明人： Ramani Bandarage ,  Upul Bandarage ,  Xinqin Fang ,  David Garvey ,  L. Letts ,  Joseph Schroeder ,  Sang Tam

    IPC分类号： A61K31/55 ,  A61K31/541 ,  A61K31/5377 ,  A61K31/496 ,  A61K31/454 ,  C07D417/02 ,  C07D413/02 ,  C07D403/02

    CPC分类号： C07D207/333 ,  C07C317/46 ,  C07C381/00 ,  C07D209/12 ,  C07D209/18 ,  C07D231/12 ,  C07D231/14 ,  C07D233/64 ,  C07D237/14 ,  C07D261/08 ,  C07D263/20 ,  C07D307/58 ,  C07D311/12 ,  C07D413/12 ,  C07D471/04

    摘要： The present invention describes novel nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) inhibitors and novel compositions comprising at least one nitrosated and/or nitrosylated cyclooxygenase 2 (COX-2) inhibitor, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or optionally, at least one therapeutic agent. The present invention also provides novel compositions comprising at least one parent COX-2 inhibitor and at least one nitric oxide donor, and, optionally, at least one therapeutic agent. The present invention also provides kits and methods for treating inflammation, pain and fever; for treating and/or improving the gastrointestinal properties of COX-2 inhibitors; for facilitating wound healing; for treating and/or preventing renal toxicity; and for treating and/or preventing other disorders resulting from elevated levels of cyclooxygenase-2.

    摘要翻译： 本发明描述了新的亚硝化和/或亚硝基化的环氧合酶2（COX-2）抑制剂和包含至少一种亚硝化和/或亚硝基化的环氧合酶2（COX-2）抑制剂的新组合物，和任选的至少一种可以提供， 转移或释放一氧化氮，刺激一氧化氮的内源性合成，提高内皮衍生的松弛因子的内源水平，或者是一氧化氮合酶的底物和/或任选的至少一种治疗剂。 本发明还提供了包含至少一种母体COX-2抑制剂和至少一种一氧化氮供体以及任选的至少一种治疗剂的新型组合物。 本发明还提供用于治疗炎症，疼痛和发烧的试剂盒和方法; 用于治疗和/或改善COX-2抑制剂的胃肠性质; 促进伤口愈合; 用于治疗和/或预防肾毒性; 并且用于治疗和/或预防由环氧合酶-2水平升高引起的其它疾病。